Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
Neoadjuvant chemotherapy (NAC) is often used to treat locally advanced disease for tumor downstaging, thus improving the chances of breast-conserving surgery. From the NAC response, it is possible to obtain prognostic information as patients may reach a pathological complete response (pCR). Those wh...
Main Authors: | Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Cassio Murilo Trovo Hidalgo Filho, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/21/5477 |
Similar Items
-
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
by: Ana Julia Aguiar de Freitas, et al.
Published: (2022-09-01) -
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01) -
Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Hiroko Miyagi, et al.
Published: (2022-12-01) -
A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression
by: Rhafaela Lima Causin, et al.
Published: (2021-03-01) -
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers
by: Ling-Ming Tseng, et al.
Published: (2023-12-01)